FDA panel drills down on metal implants reactions

FDA panel wants info on metal implant reactions (TMGPulse)
An FDA panel will meet this week to discuss immunological responses to medical device implants made of metal, including artificial hips and the Essure permanent birth control device.
The Immunology Devices Panel of the agency’s Center for Devices and Radiological Health is seeking scientific information on how metal implants or inserts elicit a prolonged and/or heightened immunological inflammatory response.
Corrosion of the metals used in artificial hips, for example, have been linked to metallosis, or metal poisoning. Symptoms include bone and tissue death, implant failure and severe pain. Implant makers have reached billions of dollars in legal settlements and researchers continue to study and test alternatives.
Bayer’s (ETR:BAYN) Essure inserts are metal coils made of polyester fibers, nickel, titanium, platinum, silver-tin and stainless steel. Designed for implant in the fallopian tubes, Essure was pulled from the U.S. market in 2018 after women reported suffering a variety of ailments after implant, including pain, bleeding and autoimmune disorders.
The discussion on Wednesday and Thursday will include patients’ local and systemic signs or symptoms or immunological response to metal-containing devices as well as the gaps in the scientific understanding of the interactions between the immune system with metal implants/inserts or their corrosion products.
The panel also wants information on factors that may increase or decrease a patient’s susceptibility to a heightened or prolonged response to a metal implant/insert, and the research needed to understand and mitigate the impacts of these factors. They include:
- Sex, age and/or female reproductive status.
- Medical comorbidities such as allergy, connective tissue diseases, other inflammatory and autoimmune diseases.
- Modifiable behaviors such as tattooing, smoking and wearing metal jewelry.
- Genetic markers and/or other biological or demographic variations.
- Location of device implant.
- Duration of implantation.
- Specific metal or metal alloy compositions.
- Surface and coating characteristics.
- Manufacturing processes.
- Corrosion/degradation products or other release of substances.
The panel also wants information on the status and clinical usefulness of diagnostic/prognostic tests administered before and after implantation to assess or manage patient reactions to implants. Experts will be asked to specify unknowns about these tests, the next steps to develop methods to reliably predict an individual’s risk of heightened response and to monitor reactions after implantation.
Finally, the panel will ask for testimony on the need for nonclinical biocompatibility assessments
of metal implants/inserts and their potential to evoke and modulate immune and inflammatory responses. Immunological responses to dental amalgams will also be discussed.
An FDA research document on the topic may be found here.
Separately, a pair of scientists at Argonne National Laboratory said last summer that they are seeking to patent a method that they say does a better job than standard ASTM tests of showing how well hip implants will endure conditions in the human body before corrosion sets in.
Tiger Recruiting
Popular Articles
🔸Mergers and Acquisitions in Orthopedics (by date)
30 lessons in 30 years of Orthopedics
The New Thinking in Orthopedics
The Future of Marketing in Orthopedics
How orthopedic startups use SPEED as a weapon
An Open Letter to the Orthopedic Companies
Dear CEO, the future of orthopedics is software
Why you should fire your R&D Leader
The Mystery of True Innovation in Orthopedics
Why the Big Orthos don’t need internal startups
Everything you need to know about the first wearable orthopedic device, TracPatch
Why good people get stuck in big Ortho companies
Honest Advice for my Ortho Friends
🔸30 lessons in 30 years of Orthopedics
Why choose to be an employee again if you can start an orthopedic company?
Why you should fire your R&D leader
Why you should fire your Marketing leader
If you have a new idea in orthopedics… Do this.
Are Startups for me? 8 Question Test
The answer to your execution is WHO first
Real career advice for young Engineers
How to judge the strength of an Orthopedic company by reading press releases
How to upgrade your LinkedIn profile
Careers @ Startups
Funding @ Startups
Building Value @ Startups
General @ Startups
Mistakes @ Startups
People @ Startups
🔸Yes, you deserve Tiger Recruiting
Dynamite for Orthopedic Companies
The Founder Effect in Orthopedic Startups
6 Hiring Mistakes that Can Kill an Orthopedic Startup
6 Early Hires that breed success in your Orthopedic Startup
It’s counterintuitive, but hiring is better with the Retained Recruiter
Your Startup hiring should be focused on “hunger”
When should you use a Retained Search versus a Contingency Search?
Why do Orthopedic companies “accidentally” hire B Players?
How to save money with your Orthopedic recruiting
Thoughts about the Orthopedic Industry
Disruptive Trends in Orthopedics
The Lists
🔸 14 Exclusive Interviews with Orthopedic Entrepreneurs
15 Orthopedics Trends Observed by Tiger
Top 21 Spine Surgeons under 40 to watch
28 Best Shoulder Surgeons in US
26 Dos and Don’ts for Creating Value in an Orthopedic Startup
50 Companies that are leading innovation in Sports Medicine
22 Best Knee Surgeons in North America
26 Best Foot & Ankle Surgeons in North America
30 Outside Product Development shops who are currently serving Orthopedics
6 Early Hires that breed success in your Orthopedic Startup